As part of its 2020 strategy to strengthen capabilities in natural flavour solutions to its customers, Givaudan today announced that it has acquired Activ International.
Activ International offers a range of natural and organic flavours, marine extracts, seafood and vegetable based culinary solutions to customers. With headquarters in Bienne (Switzerland), Activ operates from locations in Somerset (New Jersey, USA), Melaka (Malaysia), Mitry-Mory (Paris, France) and Arequipa (Peru), employing globally 170 employees.
Gilles Andrier, CEO of Givaudan said: “This acquisition fits with our 2020 strategy to expand our offering to deliver natural products to our customers. Givaudan is the global leader in the space of natural flavours and Activ further complements our capabilities with its strong portfolio of natural meat, seafood and vegetable flavours. We are delighted to welcome Activ’s employees to Givaudan; our high cultural fit will contribute greatly to a successful integration.”
Mauricio Graber, President of Givaudan’s Flavour Division said: “Consumers around the world are increasingly demanding more natural and organic products from food and beverage companies. The addition of Activ’s product portfolio further enables Givaudan to strengthen our extensive natural flavour offerings and provide customers with complete and competitive natural solutions.”
While terms of the deal have not been disclosed, Activ’s business would have represented approximately CHF 40 million of incremental sales to Givaudan’s results in 2016 on a proforma basis. Givaudan plans to fund the transaction from existing resources.
Source: Givaudan
The company expects to eliminate 1.2 billion tons carbon dioxide equivalent of methane emissions by the end of the decade. The company says that it already reduced its methane emissions by around 14% between 2018 and 2020.
The “first-of-its-kind” pilot project will develop and demonstrate an affordable modular bioprocessing system to produce biodegradable bioplastics from food waste diverted from landfills. The three-year grant will test the scalability and feasibility of the conversion on a national and global scale.
Arkeon is allying with specialty mineral giant ICL to support the scaling of its fermentation bioprocess that converts CO2 into the 20 proteinogenic essential amino acids needed in human nutrition. The process, hailed as carbon negative, is based on the use of archaea, a group of microorganisms that naturally feeds off the greenhouse gas.
